Literature DB >> 2588588

Assessing the economic impact of AIDS in local communities. Current and projected costs for San Diego County.

R L Seidman, S J Williams, L M Mortensen.   

Abstract

The economic cost of the acquired immunodeficiency syndrome (AIDS) in San Diego County, California, is forecast to increase from $103 million in 1986 to between $502 and $743 million in 1991, rising at a minimum average annual rate of 30% after adjusting for inflation. A greater emphasis on outpatient care and the use of new therapies that increase life expectancy by reducing the frequency and severity of morbidity will decrease the future annual cost of treatment but will have a small effect on total economic costs because of substantial foregone earnings by persons with AIDS. Estimating the economic impact of this disease provides valuable information for formulating effective strategies to treat AIDS patients, to provide education for limiting the spread of the human immunodeficiency virus, and to achieve other health objectives.

Entities:  

Mesh:

Year:  1989        PMID: 2588588      PMCID: PMC1026848     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  12 in total

1.  The state of the art of cost-of-illness estimates.

Authors:  T A Hodgson
Journal:  Adv Health Econ Health Serv Res       Date:  1983

2.  The economic costs of the health effects of smoking, 1984.

Authors:  D P Rice; T A Hodgson; P Sinsheimer; W Browner; A N Kopstein
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

3.  Cost analysis of AIDS cases in Maryland.

Authors:  R Berger
Journal:  Md Med J       Date:  1985-12

4.  The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States.

Authors:  A M Hardy; K Rauch; D Echenberg; W M Morgan; J W Curran
Journal:  JAMA       Date:  1986-01-10       Impact factor: 56.272

5.  Social and economic implications of cancer in the United States.

Authors:  D P Rice; T A Hodgson
Journal:  Vital Health Stat 3       Date:  1981-03

6.  Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.

Authors:  A A Scitovsky; D P Rice
Journal:  Public Health Rep       Date:  1987 Jan-Feb       Impact factor: 2.792

7.  The provision and financing of medical care for AIDS patients in US public and private teaching hospitals.

Authors:  D P Andrulis; V S Beers; J D Bentley; L S Gage
Journal:  JAMA       Date:  1987-09-11       Impact factor: 56.272

8.  Forecasting the personal medical care costs of AIDS from 1988 through 1991.

Authors:  F J Hellinger
Journal:  Public Health Rep       Date:  1988 May-Jun       Impact factor: 2.792

9.  HIV disease prevention and treatment. A model for local planning.

Authors:  K W Kizer; M A Conant; D P Francis; T Fraziear
Journal:  West J Med       Date:  1988-10

10.  The economic costs of illness: a replication and update.

Authors:  D P Rice; T A Hodgson; A N Kopstein
Journal:  Health Care Financ Rev       Date:  1985
View more
  2 in total

Review 1.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

Review 2.  Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital.

Authors:  Baba Maiyaki Musa; Usman Gebi; Mary-Ann Etiebet; Helen Omuh; Patrick Ekedegwa; Patrick Dakum; William Blattner
Journal:  J Public Health Afr       Date:  2010-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.